We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Boosters and third doses will appear on the COVID Pass in England, making it easy for people to show their vaccine status when travelling abroad.
First published during the 2019 to 2022 Johnson Conservative government
Following an increase in avian flu cases in humans in China, the UK Health Security Agency (UKHSA) is reminding people travelling to the country to avoid handling produce at wet markets.
Following a review of evidence by the Joint Committee on Vaccination and Immunisation (JCVI), advice on second doses for young people aged 16 to 17 was issued earlier this week.
The Secretary of State for Health and Social Care Sajid Javid gave the keynote address at the NHS Providers' Annual Conference and Exhibition 2021.
The UK and Swedish Missions to the UN in Geneva unveiled a brand new art exhibition to raise awareness of antimicrobial resistance to mark World Antimicrobial Awareness Week
New UKHSA data shows that bloodstream infections dropped in 2020 for the first time since 2016 but remain at a higher level than 6 years ago.
Maven® by Conduent has been selected as the new Case and Incident Management System (CIMS) that will replace UKHSA’s current system
A letter on routine annual social care funding to local authorities for the financial year 2021 to 2022.
Over one million boosters given in last 3 days as people urged to get vital top-up to their immunity.
JCVI has advised that, in addition to those aged over 50 years and at higher risk from coronavirus, all adults aged 40 to 49 years should be offered an mRNA booster.
Results from first UK real-world study by UKHSA show significantly increased protection against symptomatic disease from Pfizer-BioNTech vaccine booster dose in those aged 50 and above.
Our safety monitoring to date shows that COVID-19 vaccines continue to have a positive safety profile for the majority of people.
A £375 million investment to improve understanding and treatment for a range of neurodegenerative diseases.
12 million people in the UK have received a COVID-19 booster or third jab.
11.4 million people in the UK have now received a COVID-19 booster vaccine or third jab.
The chance for adults and children suffering from life-threatening allergic reactions to get life-saving shots of adrenaline in public places, such as restaurants and entertainment venues, has come a step closer as a result …
The labelling states an incorrect maximum daily dose for 12-15-year olds. The MHRA, who issued the recall, says that that the risk to patients is very low.
Sajid Javid's open letter to NHS trusts in England on the vital role they must play in achieving shared ambitions on climate change and the environment.
Secretary of State for Health and Social Care Sajid Javid spoke at the NHS Confederation ICS Leaders conference
The Princess Royal today visited UKHSA's Colindale site to open a new laboratory, marking 100 years of the world’s oldest existing collection of bacteria samples.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).